Brind.
  1. The Phase III VALUE clinical trial for a product developed by MediWound Ltd. is underway, involving a BARDA contract and sites across multiple countries, including the U.S. and Europe.

MediWound announced findings from its clinical trial conducted in Yavne.

1 report, 1 independent Updated Aug 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

MediWound announced findings from its clinical trial conducted in Yavne.

Who's involved

What this event is mainly about
MediWound (Germany)Yavne

Keep exploring

Part of

The Phase III VALUE clinical trial for a product developed by MediWound Ltd. is underway, involving a BARDA contract and sites across multiple countries, including the U.S. and Europe. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireMediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers MediWound Announces New EscharEx® Phase II Data Demonstr